KATHRYN LYONS: Open Payments
NPI 1962808881 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$353 in 5 payments from 5 companies in 2025. Trend: 2023 $22 · 2024 $62 · 2025 $353
Food & beverage: $353
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $118 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $115 |
| Stryker Corporation | 1 | $72 |
| Bioventus LLC | 1 | $33 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $16 |
Products named: XIFAXAN, CAPLYTA, PANGEA, DUROLANE, JOURNAVX.
Industry payments across LA — which companies pay providers there.
